Join us at FT Global Pharma and Biotech Summit 2025! Alexion’s SVP, EUCAN & International Business, Soraya Bekkali, will take the stage for an engaging panel discussion about the impressive progress that has been made in advancing rare disease innovation as well as the challenges around diagnosis, data diversity and research funding that remain.
Patricia C.
3w
Each summit like this is a reminder of how far we’ve come in rare disease innovation—and how much collaboration is still needed to close diagnostic and data gaps. Grateful to see Alexion leading with purpose and scientific depth in this mission.
Simplesmente extraordinária!